US expects to approve UK-backed AstraZeneca-Oxford vaccine in April

The United States is expected to approve the low-cost AstraZeneca/Oxford vaccine in April, a senior official says — more than three months after Britain’s green light on Monday.

Moncef Slaoui, the chief advisor to Operation Warp Speed, the military-led US effort for vaccines, does not question Britain’s move but tells reporters that US trials will be complete for approval “sometime in early April.”

This photo issued by the University of Oxford shows a vial of coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. (John Cairns/University of Oxford via AP)